phosphorylcholine has been researched along with Carcinoma, Renal Cell in 5 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Perifosine is an oral alkylphospholipid which has recently been assessed clinically in patients with advanced renal cell carcinoma (RCC)." | 2.49 | Perifosine in renal cell carcinoma. ( Cho, DC; Srivastava, N, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holland, WS | 1 |
| Tepper, CG | 1 |
| Pietri, JE | 1 |
| Chinn, DC | 1 |
| Gandara, DR | 1 |
| Mack, PC | 1 |
| Lara, PN | 1 |
| Cho, DC | 2 |
| Hutson, TE | 1 |
| Samlowski, W | 1 |
| Sportelli, P | 1 |
| Somer, B | 1 |
| Richards, P | 1 |
| Sosman, JA | 1 |
| Puzanov, I | 1 |
| Michaelson, MD | 1 |
| Flaherty, KT | 1 |
| Figlin, RA | 1 |
| Vogelzang, NJ | 1 |
| Srivastava, N | 1 |
| Settelen, N | 1 |
| Roch, O | 1 |
| Bock, D | 1 |
| Rooke, R | 1 |
| Braun, S | 1 |
| Meyer, O | 1 |
| Barna, BP | 1 |
| James, K | 1 |
| Deodhar, SD | 1 |
1 review available for phosphorylcholine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Perifosine in renal cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Disease-Free Survival; Humans; Kidney Neoplasms; Molec | 2013 |
1 trial available for phosphorylcholine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Renal Cell; Disease Progression; Female; Follow-Up Studies; Huma | 2012 |
3 other studies available for phosphorylcholine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Resist | 2012 |
Controlled plasmid gene transfer to murine renal carcinoma by hexadecylphosphocholine.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Delayed-Action Preparations; Dose-Response Relatio | 2004 |
Activation of human monocyte tumoricidal activity by C-reactive protein.
Topics: Astrocytes; Astrocytoma; C-Reactive Protein; Carcinoma, Renal Cell; Cell Line; Cytotoxicity Tests, I | 1987 |